Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.2970
+0.01796.41%
Post-market: 0.29940.0024+0.81%19:17 EDT
Volume:122.79K
Turnover:35.45K
Market Cap:5.98M
PE:-0.16
High:0.2996
Open:0.2880
Low:0.2802
Close:0.2791
52wk High:5.12
52wk Low:0.2604
Shares:20.12M
Float Shares:17.66M
Volume Ratio:0.18
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-1.21
PE(LYR):-0.14

Loading ...

Vivos Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
May 12

Vivos Therapeutics Faces Nasdaq Listing Compliance Challenges

TIPRANKS
·
Apr 23

Vivos Therapeutics gets Nasdaq notice for failing minimum stockholders’ equity rule

Reuters
·
Apr 23

Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Apr 22

Vivos Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 17

Analysts Conflicted on These Healthcare Names: Vivos Therapeutics (VVOS), Certara (CERT) and Option Care Health (OPCH)

TIPRANKS
·
Apr 17

Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright

TIPRANKS
·
Apr 17

Vivos Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $2.5 From $7

THOMSON REUTERS
·
Apr 17

Vivos Therapeutics Balances Growth Hopes With Cash Strain

TIPRANKS
·
Apr 17

Vivos Therapeutics Q4 EPS $(0.58) Misses $(0.48) Estimate, Sales $3.824M Miss $6.447M Estimate

Benzinga Earnings
·
Apr 16

Vivos Therapeutics FY25 net loss widens to $21.2 million; revenue rises 16% to $17.5 million

Reuters
·
Apr 16

Vivos Therapeutics Reports Full Year 2025 Financial Results

THOMSON REUTERS
·
Apr 16

Vivos Therapeutics to report full-year results, host investor conference call

Reuters
·
Apr 15

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

GlobeNewswire
·
Apr 15

Vivos Therapeutics says V-Co Investors 3 files initial beneficial ownership statement

Reuters
·
Apr 11

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

GlobeNewswire
·
Apr 07

Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday

Benzinga_recent_news
·
Apr 06

Vivos Therapeutics Completes Private Placement to Bolster Liquidity

TIPRANKS
·
Apr 04

Vivos Therapeutics raises $2.3 million in private placement with Seneca affiliate

Reuters
·
Apr 04

Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours

Benzinga_recent_news
·
Apr 03